Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...

Swiss pharma heavyweight Novartis is cutting a very large check. The company has agreed to acquire London-headquartered ...

Ligand Pharma (LGND) stock jumped in the final week of June, but the proximate cause was the pricing of $625M of convertible ...

According to a Bloomberg report citing a Morgan Stanley note, the firm picked Microsoft, Amazon, and Meta as its favorites ...

A Delaware judge dismissed a former Aurion Biotech executive's challenge to a stockholder's alleged takeover of the company, ...

Met a bulin, a Texas-based biotechnology company led by Hua Tu, PhD, is working to develop an ultra-stable insulin formulation that remains viable even at high temperatures. “Insulin instability has ...

Morgan Stanley’s pivot is from “chip winners” to hyperscalers with AI infrastructure optionality. MSFT has the strongest mix ...

Hyperscalers may benefit as chip stocks struggle, according to Morgan Stanley strategists. The once-hot semiconductor trade has seen a cooling in the last couple of weeks, which is not only likely to ...

Hyperscalers may benefit as chip stocks struggle, according to Morgan Stanley strategists. The once-hot semiconductor trade has seen a cooling in the last couple of weeks, which is not only likely to ...

The future food industry in the Netherlands is calling on the government to make at least €200M available via the EU's IPCEI mechanism to scale up alternative proteins.

According to Abivax, fresh data suggest malignancy rates in its trials were no higher than "background" ones for people with ...

Stevenage Bioscience Catalyst held a celebration of the life of its late CEO Dr Sally Ann Forsyth OBE DSc at a memorial gathering today (Wednesday). Sally Ann recently passed away following a long ...